Mannitol IP 20% Infusion
Marketer
Baxter India Pvt Ltd
Salt Composition
Mannitol (20% w/v)
Overview Mannitol IP 20% Infusion
Mannitol 20% Injection (IP) is a therapeutic agent employed in managing acute kidney failure, cerebral edema (brain fluid buildup), and elevated intraocular pressure associated with glaucoma. Its mechanism involves diuresis (excess fluid removal) and inflammation reduction in affected tissues. This medication can be used independently or concurrently with other treatments. Intravenous administration is exclusively under medical supervision; self-administration is strictly prohibited. Dosage and duration must adhere to physician instructions. Missed doses should be taken promptly upon recollection. Common adverse effects include nausea, vomiting, headache, and dehydration. Injection site reactions—pain, redness, or swelling—may also occur but are typically transient and self-limiting. Persistent or bothersome side effects necessitate immediate medical consultation. Regular blood monitoring may be necessary during treatment.
Uses of Mannitol IP 20% Infusion
Kidney failure (sudden onset)|Brain swelling due to fluid buildup|Increased intraocular pressure
Major Benefits of Mannitol IP 20% Infusion:
This medication will be administered by your healthcare provider. Unauthorized self-medication is prohibited.
Common Side effects of Mannitol IP 20% Infusion:
- Nausea
- Vomiting
- Headache
- Dehydration
- Injection site reactions (pain, swelling, redness)
How to use Mannitol IP 20% Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Mannitol IP 20% Infusion works:
A 20% Mannitol IP infusion, a non-reactive osmotic diuretic, elevates urinary output by osmotically drawing fluid from body tissues into the renal system. This solution is also employed to reduce intraocular pressure and cerebral edema.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Mannitol IP 20% Infusion is undetermined regarding safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The safety of 20% Mannitol Infusion IP during pregnancy is uncertain. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the risks and advantages before prescribing it. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of 20% mannitol infusion (IP) during lactation is likely safe. Available human data indicates minimal infant risk associated with this medication.
DrivingSAFE
Driving ability is typically unaffected by intravenous administration of 20% mannitol.
KidneySAFE IF PRESCRIBED
Employing a 20% Mannitol IP infusion in patients with renal impairment appears to present a low risk. Existing evidence indicates dose modification for Mannitol IP 20% infusions may be unnecessary in this population; however, physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of 20% Mannitol IP infusion to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Mannitol IP 20% Infusion :
Should you forget a dose of your 20% Mannitol IP infusion, seek immediate medical advice.
Facts to Know About Mannitol IP 20% Infusion
| Label | Value |
|---|---|
| Pharmaceutical Category | Polyols |
| Potential for Dependence | None. |
| Type of Treatment | HEART |
| Mechanism of Action | Water-excreting medications |
3,018 People bought this recently